184 related articles for article (PubMed ID: 8859181)
1. Peritoneal carcinomatosis in patients with digestive endocrine tumors.
Vasseur B; Cadiot G; Zins M; Fléjou JF; Belghiti J; Marmuse JP; Vilgrain V; Bernades P; Mignon M; Ruszniewski P
Cancer; 1996 Oct; 78(8):1686-92. PubMed ID: 8859181
[TBL] [Abstract][Full Text] [Related]
2. Surgical treatment of peritoneal carcinomatosis from well-differentiated digestive endocrine carcinomas.
Elias D; Sideris L; Liberale G; Ducreux M; Malka D; Lasser P; Duvillard P; Baudin E
Surgery; 2005 Apr; 137(4):411-6. PubMed ID: 15800487
[TBL] [Abstract][Full Text] [Related]
3. Different splice variants of CD44 are expressed in gastrinomas but not in other subtypes of endocrine pancreatic tumors.
Chaudhry A; Gobl A; Eriksson B; Skogseid B; Oberg K
Cancer Res; 1994 Feb; 54(4):981-6. PubMed ID: 7508823
[TBL] [Abstract][Full Text] [Related]
4. Prospective study of the value of serum chromogranin A or serum gastrin levels in the assessment of the presence, extent, or growth of gastrinomas.
Goebel SU; Serrano J; Yu F; Gibril F; Venzon DJ; Jensen RT
Cancer; 1999 Apr; 85(7):1470-83. PubMed ID: 10193936
[TBL] [Abstract][Full Text] [Related]
5. [Management of digestive system carcinoid tumors and carcinoid syndrome].
Mondragón Sánchez RJ; Castillero Pinilla C; Saldívar Moreno C; Oñate Ocaña LF; Ruiz Molina JM; Aiello Crocifoglio V
Rev Gastroenterol Mex; 1998; 63(4):204-10. PubMed ID: 10319670
[TBL] [Abstract][Full Text] [Related]
6. Gastrinomas associated with MEN-1 syndrome: new insights for the diagnosis and management in a series of 11 patients.
Nikou GC; Toubanakis C; Nikolaou P; Giannatou E; Marinou K; Safioleas M; Karamanolis D
Hepatogastroenterology; 2005; 52(66):1668-76. PubMed ID: 16334754
[TBL] [Abstract][Full Text] [Related]
7. Survival from malignant digestive endocrine tumors in England and Wales: a population-based study.
Lepage C; Rachet B; Coleman MP
Gastroenterology; 2007 Mar; 132(3):899-904. PubMed ID: 17383419
[TBL] [Abstract][Full Text] [Related]
8. Morbidity and mortality of aggressive resection in patients with advanced neuroendocrine tumors.
Norton JA; Kivlen M; Li M; Schneider D; Chuter T; Jensen RT
Arch Surg; 2003 Aug; 138(8):859-66. PubMed ID: 12912744
[TBL] [Abstract][Full Text] [Related]
9. Hepatic arterial embolization and chemoembolization for the treatment of patients with metastatic neuroendocrine tumors: variables affecting response rates and survival.
Gupta S; Johnson MM; Murthy R; Ahrar K; Wallace MJ; Madoff DC; McRae SE; Hicks ME; Rao S; Vauthey JN; Ajani JA; Yao JC
Cancer; 2005 Oct; 104(8):1590-602. PubMed ID: 16134179
[TBL] [Abstract][Full Text] [Related]
10. [Digestive system carcinoid tumor and synchronous malignant tumors].
Berner M
Schweiz Med Wochenschr; 1993 Apr; 123(13):594-9. PubMed ID: 8480156
[TBL] [Abstract][Full Text] [Related]
11. Is adjuvant therapy with streptozotocin and 5-fluorouracil useful after resection of liver metastases from digestive endocrine tumors?
Maire F; Hammel P; Kianmanesh R; Hentic O; Couvelard A; Rebours V; Zappa M; Raymond E; Sauvanet A; Louvet C; Lévy P; Belghiti J; Ruszniewski P
Surgery; 2009 Jan; 145(1):69-75. PubMed ID: 19081477
[TBL] [Abstract][Full Text] [Related]
12. Carcinoids of the jejunum and ileum: an immunohistochemical and clinicopathologic study of 167 cases.
Burke AP; Thomas RM; Elsayed AM; Sobin LH
Cancer; 1997 Mar; 79(6):1086-93. PubMed ID: 9070484
[TBL] [Abstract][Full Text] [Related]
13. Loss of heterozygosity of chromosome 1q in gastrinomas: occurrence and prognostic significance.
Chen YJ; Vortmeyer A; Zhuang Z; Huang S; Jensen RT
Cancer Res; 2003 Feb; 63(4):817-23. PubMed ID: 12591732
[TBL] [Abstract][Full Text] [Related]
14. Liver resection (and associated extrahepatic resections) for metastatic well-differentiated endocrine tumors: a 15-year single center prospective study.
Elias D; Lasser P; Ducreux M; Duvillard P; Ouellet JF; Dromain C; Schlumberger M; Pocard M; Boige V; Miquel C; Baudin E
Surgery; 2003 Apr; 133(4):375-82. PubMed ID: 12717354
[TBL] [Abstract][Full Text] [Related]
15. Carcinoid tumors of the duodenum.
Mullen JT; Wang H; Yao JC; Lee JH; Perrier ND; Pisters PW; Lee JE; Evans DB
Surgery; 2005 Dec; 138(6):971-7; discussion 977-8. PubMed ID: 16360380
[TBL] [Abstract][Full Text] [Related]
16. Gastrointestinal carcinoids. Prognosis and survival.
Caprotti R; Angelini C; Mussi C; Romano F; Sartori P; Scaini A; Muselli P; Uggeri F
Minerva Chir; 2003 Aug; 58(4):523-28,529-32. PubMed ID: 14603164
[TBL] [Abstract][Full Text] [Related]
17. Description of patients with midgut carcinoid tumours: clinical database from a Danish centre.
Nykjaer KM; Grønbaek H; Nielsen DT; Christiansen P; Astrup LB
In Vivo; 2007; 21(4):679-84. PubMed ID: 17708366
[TBL] [Abstract][Full Text] [Related]
18. Two-step surgery for synchronous bilobar liver metastases from digestive endocrine tumors: a safe approach for radical resection.
Kianmanesh R; Sauvanet A; Hentic O; Couvelard A; Lévy P; Vilgrain V; Ruszniewski P; Belghiti J
Ann Surg; 2008 Apr; 247(4):659-65. PubMed ID: 18362629
[TBL] [Abstract][Full Text] [Related]
19. Prospective study of the antitumor efficacy of long-term octreotide treatment in patients with progressive metastatic gastrinoma.
Shojamanesh H; Gibril F; Louie A; Ojeaburu JV; Bashir S; Abou-Saif A; Jensen RT
Cancer; 2002 Jan; 94(2):331-43. PubMed ID: 11900219
[TBL] [Abstract][Full Text] [Related]
20. Digestive calcitonin-secreting tumors of the foregut: comparison with non-calcitonin-secreting tumors.
Wuilmet L; Jovenin N; Larbre H; Lévy-Bohbot N; Diebold MD; Jolly D; Delemer B; Thiéfin G; Cadiot G
Eur J Gastroenterol Hepatol; 2006 Sep; 18(9):951-5. PubMed ID: 16894307
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]